Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Pharmacokinetics and safety of fontolizumab in Crohn's disease

June 1, 2004

Therapeutic benefits of cilansetron in IBS

June 1, 2004

Update on natalizumab in Crohn's disease

June 1, 2004

Pioglitazone improves features of nonalcoholic steatohepatitis

May 28, 2004

Renzapride improves bowel function and reduces abdominal pain/discomfort in IBS

May 28, 2004

BPC-157 reported to promote ulcer healing in rats

May 28, 2004

Visilizumab found effective in refractory ulcerative colitis

May 28, 2004

Benefits associated with IB-MECA in a model of experimental colitis

May 27, 2004

Vertex plans METRO study for merimepodib

May 27, 2004

Oral MNTX formulations complete phase I trials

May 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...